BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26796350)

  • 21. Elevated donor plasminogen activator inhibitor-1 levels and the risk of primary graft dysfunction.
    Hamilton BCS; Dincheva GR; Zhuo H; Golden JA; Brzezinski M; Singer JP; Matthay MA; Kukreja J
    Clin Transplant; 2018 Apr; 32(4):e13210. PubMed ID: 29377268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation.
    Sayah DM; Mallavia B; Liu F; Ortiz-Muñoz G; Caudrillier A; DerHovanessian A; Ross DJ; Lynch JP; Saggar R; Ardehali A; ; Ware LB; Christie JD; Belperio JA; Looney MR
    Am J Respir Crit Care Med; 2015 Feb; 191(4):455-63. PubMed ID: 25485813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation: long-term survival.
    Bermudez CA; Adusumilli PS; McCurry KR; Zaldonis D; Crespo MM; Pilewski JM; Toyoda Y
    Ann Thorac Surg; 2009 Mar; 87(3):854-60. PubMed ID: 19231405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Procalcitonin accurately predicts lung transplant adults with low risk of pulmonary graft dysfunction and intensive care mortality.
    Mazo C; Borgatta B; Pont T; Sandiumenge A; Moyano S; Roman A; Rello J
    J Crit Care; 2018 Apr; 44():142-147. PubMed ID: 29112904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation.
    Shah RJ; Bellamy SL; Localio AR; Wickersham N; Diamond JM; Weinacker A; Lama VN; Bhorade S; Belperio JA; Crespo M; Demissie E; Kawut SM; Wille KM; Lederer DJ; Lee JC; Palmer SM; Orens J; Reynolds J; Shah A; Wilkes DS; Ware LB; Christie JD
    J Heart Lung Transplant; 2012 Sep; 31(9):942-9. PubMed ID: 22694851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracorporeal membrane oxygenation for grade 3 primary graft dysfunction after lung transplantation: Long-term outcomes.
    Bellier J; Lhommet P; Bonnette P; Puyo P; Le Guen M; Roux A; Parquin F; Chapelier A; Sage E;
    Clin Transplant; 2019 Mar; 33(3):e13480. PubMed ID: 30657612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction.
    Christie JD; Shah CV; Kawut SM; Mangalmurti N; Lederer DJ; Sonett JR; Ahya VN; Palmer SM; Wille K; Lama V; Shah PD; Shah A; Weinacker A; Deutschman CS; Kohl BA; Demissie E; Bellamy S; Ware LB;
    Am J Respir Crit Care Med; 2009 Nov; 180(10):1010-5. PubMed ID: 19661249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Value of preoperative pulmonary artery diastolic pressure on predicting primary graft dysfunction after bilateral lung transplantation for patients with idiopathic pulmonary fibrosis].
    Zhang F; Xu H; Jiang S; Li J; Lu S; Wang D; Zang Z; Pan H; Chen J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 May; 29(5):442-447. PubMed ID: 28524034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers.
    Shen J; Chan HL; Wong GL; Chan AW; Choi PC; Chan HY; Chim AM; Yeung DK; Yu J; Chu WC; Wong VW
    Aliment Pharmacol Ther; 2012 Dec; 36(11-12):1057-66. PubMed ID: 23066946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary graft dysfunction and long-term pulmonary function after lung transplantation.
    Whitson BA; Prekker ME; Herrington CS; Whelan TP; Radosevich DM; Hertz MI; Dahlberg PS
    J Heart Lung Transplant; 2007 Oct; 26(10):1004-11. PubMed ID: 17919620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postoperative estradiol levels associate with development of primary graft dysfunction in lung transplantation patients.
    Bastarache JA; Diamond JM; Kawut SM; Lederer DJ; Ware LB; Christie JD
    Gend Med; 2012 Jun; 9(3):154-65. PubMed ID: 22361838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association Between Prolonged Graft Ischemia and Primary Graft Failure or Survival Following Lung Transplantation.
    Grimm JC; Valero V; Kilic A; Magruder JT; Merlo CA; Shah PD; Shah AS
    JAMA Surg; 2015 Jun; 150(6):547-53. PubMed ID: 25874575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation.
    Prekker ME; Nath DS; Walker AR; Johnson AC; Hertz MI; Herrington CS; Radosevich DM; Dahlberg PS
    J Heart Lung Transplant; 2006 Apr; 25(4):371-8. PubMed ID: 16563963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pretransplant dyslipidaemia influences primary graft dysfunction after lung transplantation.
    Cottini SR; Ehlers UE; Pagnamenta A; Brandi G; Weder W; Schuepbach RA; Béchir M; Benden C
    Interact Cardiovasc Thorac Surg; 2016 Apr; 22(4):402-5. PubMed ID: 26718318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ventilation parameters and early graft function in double lung transplantation.
    Schwarz S; Benazzo A; Dunkler D; Muckenhuber M; Sorbo LD; Di Nardo M; Sinn K; Moser B; Matilla JR; Lang G; Taghavi S; Vamos FR; Jaksch P; Cypel M; Keshavjee S; Klepetko W; Hoetzenecker K
    J Heart Lung Transplant; 2021 Jan; 40(1):4-11. PubMed ID: 33144029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. M30/M65 ratio predicts the outcome of paclitaxel chemotherapy for NSCLC.
    Chu T; Jiang L; Ying W; Han B
    Clin Transl Oncol; 2017 Mar; 19(3):326-331. PubMed ID: 27468866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic value of serum M30 and M65 in patients with nasopharyngeal carcinoma.
    Sen F; Yildiz I; Odabas H; Tambas M; Kilic L; Karadeniz A; Altun M; Ekenel M; Serilmez M; Duranyildiz D; Bavbek S; Basaran M
    Tumour Biol; 2015 Feb; 36(2):1039-44. PubMed ID: 25326440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variation in PTX3 is associated with primary graft dysfunction after lung transplantation.
    Diamond JM; Meyer NJ; Feng R; Rushefski M; Lederer DJ; Kawut SM; Lee JC; Cantu E; Shah RJ; Lama VN; Bhorade S; Crespo M; Demissie E; Sonett J; Wille K; Orens J; Weinacker A; Weill D; Arcasoy S; Shah PD; Belperio JA; Wilkes D; Ware LB; Palmer SM; Christie JD;
    Am J Respir Crit Care Med; 2012 Sep; 186(6):546-52. PubMed ID: 22822025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study.
    Lederer DJ; Kawut SM; Wickersham N; Winterbottom C; Bhorade S; Palmer SM; Lee J; Diamond JM; Wille KM; Weinacker A; Lama VN; Crespo M; Orens JB; Sonett JR; Arcasoy SM; Ware LB; Christie JD;
    Am J Respir Crit Care Med; 2011 Nov; 184(9):1055-61. PubMed ID: 21799077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Center Volume and Extracorporeal Membrane Oxygenation Support at Lung Transplantation in the Lung Allocation Score Era.
    Hayes D; Tobias JD; Tumin D
    Am J Respir Crit Care Med; 2016 Aug; 194(3):317-26. PubMed ID: 26840155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.